Clinical Trial Update: Bovine Carotid Artery Biologic Graft and Expanded Polytetrafluoroethylene for Permanent Hemodialysis Access [NA]

View source ↗

Summary

Clinical trial of bovine carotid artery biologic graft and expanded PTFE for permanent hemodialysis access was terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriovenous Graft
• End-stage Renal Disease
• Hemolysis

Drugs mentioned

• bovine carotid artery biologic graft
• expanded polytetrafluoroethylene (expanded PTFE)

Snippet

Sponsor: Johns Hopkins University | Conditions: End Stage Renal Disease, Hemolysis | NA | Status: TERMINATED | Results posted: 2019-05-14